HISTORY, EPIDEMIOLOGY AND CLINICAL CHARACTERISTICS OF ADVERSE EVENTS: DATA REVIEW
- Авторлар: Kozulina I.E1, Danilov A.B1, Andrianov V.V1
-
Мекемелер:
- Institute of Interdisciplinary Medicine
- Шығарылым: № 6 (2018)
- Беттер: 93-97
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/295393
- ID: 295393
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
Despite the fact that modern medicines are produced according to modern requirements, the problem of development of adverse reactions remains very relevant. The most common adverse reactions include gastrointestinal bleeding and allergic reactions. The development of the pharmacovigilance service allows one to control the frequency of such reactions and to identify new ones noted already with a wide use in the population.
Негізгі сөздер
Толық мәтін
Авторлар туралы
I. Kozulina
Institute of Interdisciplinary Medicine
Email: kozulina@idm.institute
PhD, Allergologist-Immunologist, Head of the Department of Organizing Scientific Research and Pharmacovigilance Systems, Manager at the Department of Scientific Studies Moscow, Russia
A. Danilov
Institute of Interdisciplinary MedicineMoscow, Russia
V. Andrianov
Institute of Interdisciplinary MedicineMoscow, Russia
Әдебиет тізімі
- Dave V. Current trends in Pharmacovigilance. J. Pharmacovigilance. 2013;1(2). http://dx.doi. org/10.4172/2329-6887.1000e104.
- Кантемирова Б.И., Тимофеева Н.В., Григанов В.И., Шилова А.А. Проблема нежелательных побочных реакций лекарственных средств. Астраханcкий медицинский журн. 2011;6(4):8-12.
- Лукина Ю.В., Дмитриева Н.А., Захарова А.В., и др. Нежелательные явления лекарственной терапии (первые результаты исследования по данным амбулаторного регистра Профиль). Рациональная фармакотерапия в кардиологии. 2016;12(3):306-13.
- Wester K., Jönsson A.K., Spigset O., et al. Incidence of fatal adverse drug reactions: a population based study. Br. J. Clin. Pharmacol. 2008;65(4):573-79. doi: 10.1111/j.1365-2125.2007.03064.x.
- Chan A., et al. Cost evaluation of adverse drug reaction in hospitalized patient in Taiwan: f prospective, descriptive, observational study. Curr Ther. Res. 2008;69(2). Doi: 101016/j. curtheres.2008.04.005.
- Sultana J., Cutroneo P. Clinical and economic burden of adverse drug reactions. J. Pharmacol. Pharmacother. 2013; 4(Suppl. 1):73-7.
- Pirmohamed M., James S., Meakin S., et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ. 2004;329:15-9.
- Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reaction in hospitalized patients: meta-analysis of prospective studies. JAMA. 1998;279:1200-205.
- Makary M.A., Daniel M. Medical error the third leading cause of death in the US. BMJ. 2016;353:i2139.
- McBride W. Teratogen Thalidomide embryopathy. Teratol. 1977;16(1). Doi: 10.1002/ tera.1420160113.
- Lenz W. Thalidomide and congenital abnormalities. J. Lancet. 1962;1:45.
- Загородникова К.А. Организация мониторинга безопасности лекарственных средств в мире - методологические подходы. Тихоокеанский медицинский журнал. 2015; 1:12-5.
- World Health Organization Collaborating center for international drug monitoring. Adverse reaction terminology. 31 December 1991.
- Викторов А.П. Контроль за безопасностью лекарственных препаратов в мире и проблемы развития фармакологического надзора в Украине. Провизор. 2002;1:9-13.
- Лепахин В.К. Современное состояние проблемы безопасности лекарственных средств. Международное сотрудничество. Контроль безопасности лекарств: материалы семинара: всемирного национального конгресса «Человек и лекарство». М., 1998. С. 2-15.
- Нормативные правовые акты в сфере обращения лекарственных средств в рамках евразийского экономического союза. Фармаконадзор. Ремедиум. 2017;6:18.
- Edwards I.R., Biriell C. Harmonisation in pharmacovigilance. Drug safety. 1994; 10:93-102.
- Meyboom R.H.B., Lindquist M., Egberts A.C.G. An ABC of drug-related problems. Drug safety. 2000;22:415-23.
- Fattinger K., Roos M., Verge res P, et al. Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br. J. Clin. Pharmacology. 2000;49:158-67.
- Bouvy J.C., De Bruin M.L., Koopmanschap M.A. Epidemiology of advers drug reactions in Europe: a review of recent observational studies. Drug safety. 2015;38:437-53. Doi: 10.1007/ s40264-015-0281-0.
Қосымша файлдар
